MDMB-4en-PINACA: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:MDMB-4en-PINACA}} | |||
== | == MDMB-4en-PINACA == | ||
[[File:MDMB-4en-PINACA.svg|thumb|right|Chemical structure of MDMB-4en-PINACA]] | |||
'''MDMB-4en-PINACA''' is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the [[cannabinoid receptor]]s, which are part of the [[endocannabinoid system]] in the human body. This compound is often found in "[[spice (drug)|spice]]" or "[[K2 (drug)|K2]]" products, which are marketed as legal alternatives to [[cannabis]]. | |||
== Chemical Structure and Properties == | |||
MDMB-4en-PINACA is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a methyl ester group and a pentyl chain, which contribute to its high affinity for cannabinoid receptors. The compound is typically synthesized in clandestine laboratories and sold in various forms, including powders and herbal mixtures. | |||
== Pharmacology == | == Pharmacology == | ||
MDMB-4en-PINACA acts as a full agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] receptors, which are primarily responsible for the psychoactive effects of cannabinoids. The activation of these receptors by MDMB-4en-PINACA can lead to effects similar to those of [[tetrahydrocannabinol]] (THC), the active component of cannabis, but often with greater potency and risk of adverse effects. | |||
== Effects and Risks == | |||
The use of MDMB-4en-PINACA can result in a range of effects, including euphoria, altered perception, and relaxation. However, due to its high potency, it can also cause severe adverse effects such as [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], [[anxiety]], [[paranoia]], and [[hallucinations]]. In some cases, it has been associated with [[seizures]] and [[acute kidney injury]]. | |||
== Legal | == Legal Status == | ||
Due to its potential for abuse and lack of medical use, MDMB-4en-PINACA is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and other novel psychoactive substances. | |||
== Related Pages == | |||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[Endocannabinoid system]] | |||
* [[Designer drug]] | * [[Designer drug]] | ||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Designer drugs]] | [[Category:Designer drugs]] | ||
Latest revision as of 11:41, 15 February 2025
MDMB-4en-PINACA[edit]
MDMB-4en-PINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. This compound is often found in "spice" or "K2" products, which are marketed as legal alternatives to cannabis.
Chemical Structure and Properties[edit]
MDMB-4en-PINACA is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a methyl ester group and a pentyl chain, which contribute to its high affinity for cannabinoid receptors. The compound is typically synthesized in clandestine laboratories and sold in various forms, including powders and herbal mixtures.
Pharmacology[edit]
MDMB-4en-PINACA acts as a full agonist at the CB1 and CB2 receptors, which are primarily responsible for the psychoactive effects of cannabinoids. The activation of these receptors by MDMB-4en-PINACA can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis, but often with greater potency and risk of adverse effects.
Effects and Risks[edit]
The use of MDMB-4en-PINACA can result in a range of effects, including euphoria, altered perception, and relaxation. However, due to its high potency, it can also cause severe adverse effects such as tachycardia, hypertension, nausea, vomiting, anxiety, paranoia, and hallucinations. In some cases, it has been associated with seizures and acute kidney injury.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, MDMB-4en-PINACA is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and other novel psychoactive substances.
